109 related articles for article (PubMed ID: 19065693)
1. The binding mode of petrosaspongiolide M to the human group IIA phospholipase A(2): exploring the role of covalent and noncovalent interactions in the inhibition process.
Monti MC; Casapullo A; Cavasotto CN; Tosco A; Dal Piaz F; Ziemys A; Margarucci L; Riccio R
Chemistry; 2009; 15(5):1155-63. PubMed ID: 19065693
[TBL] [Abstract][Full Text] [Related]
2. Effects of petrosaspongiolide R on the surface topology of bee venom PLA(2): a limited proteolysis and mass spectrometry analysis.
Monti MC; Riccio R; Casapullo A
Bioorg Chem; 2009 Feb; 37(1):6-10. PubMed ID: 18945473
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of phospholipase A2 inhibition by petrosaspongiolide M.
Dal Piaz F; Casapullo A; Randazzo A; Riccio R; Pucci P; Marino G; Gomez-Paloma L
Chembiochem; 2002 Jul; 3(7):664-71. PubMed ID: 12325001
[TBL] [Abstract][Full Text] [Related]
4. The molecular mechanism of human group IIA phospholipase A2 inactivation by bolinaquinone.
Monti MC; Chini MG; Margarucci L; Tosco A; Riccio R; Bifulco G; Casapullo A
J Mol Recognit; 2009; 22(6):530-7. PubMed ID: 19621421
[TBL] [Abstract][Full Text] [Related]
5. Further insights on the structural aspects of PLA(2) inhibition by gamma-hydroxybutenolide-containing natural products: a comparative study on petrosaspongiolides M-R.
Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
Bioorg Med Chem; 2004 Mar; 12(6):1467-74. PubMed ID: 15018920
[TBL] [Abstract][Full Text] [Related]
6. The binding mode of cladocoran A to the human group IIA phospholipase A(2).
Monti MC; Chini MG; Margarucci L; Riccio R; Bifulco G; Casapullo A
Chembiochem; 2011 Nov; 12(17):2686-91. PubMed ID: 21953776
[TBL] [Abstract][Full Text] [Related]
7. PLA2-mediated catalytic activation of its inhibitor 25-acetyl-petrosaspongiolide M: serendipitous identification of a new PLA2 suicide inhibitor.
Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
FEBS Lett; 2004 Dec; 578(3):269-74. PubMed ID: 15589831
[TBL] [Abstract][Full Text] [Related]
8. The inactivation mechanism of human group IIA phospholipase A(2) by Scalaradial.
Margarucci L; Monti MC; Chini MG; Tosco A; Riccio R; Bifulco G; Casapullo A
Chembiochem; 2012 Oct; 13(15):2259-64. PubMed ID: 23008213
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site.
Singh N; Kumar RP; Kumar S; Sharma S; Mir R; Kaur P; Srinivasan A; Singh TP
J Mol Recognit; 2009; 22(6):437-45. PubMed ID: 19462410
[TBL] [Abstract][Full Text] [Related]
10. Nonantibiotic properties of tetracyclines: structural basis for inhibition of secretory phospholipase A2.
Dalm D; Palm GJ; Aleksandrov A; Simonson T; Hinrichs W
J Mol Biol; 2010 Apr; 398(1):83-96. PubMed ID: 20211188
[TBL] [Abstract][Full Text] [Related]
11. Secreted phospholipase A2-IIA modulates key regulators of proliferation on astrocytoma cells.
Martín R; Hernández M; Ibeas E; Fuentes L; Salicio V; Arnés M; Nieto ML
J Neurochem; 2009 Nov; 111(4):988-99. PubMed ID: 19737348
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights on petrosaspongiolide M inhibitory effects on immunoproteasome and autophagy.
Monti MC; Margarucci L; Riccio R; Bonfili L; Mozzicafreddo M; Eleuteri AM; Casapullo A
Biochim Biophys Acta; 2014 Apr; 1844(4):713-21. PubMed ID: 24530967
[TBL] [Abstract][Full Text] [Related]
13. Exploring the binding of inhibitors derived from tetrabromobenzimidazole to the CK2 protein using a QM/MM-PB/SA approach.
Retegan M; Milet A; Jamet H
J Chem Inf Model; 2009 Apr; 49(4):963-71. PubMed ID: 19354274
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2.
Dharmappa KK; Kumar RV; Nataraju A; Mohamed R; Shivaprasad HV; Vishwanath BS
Planta Med; 2009 Feb; 75(3):211-5. PubMed ID: 19085684
[TBL] [Abstract][Full Text] [Related]
15. Chemical proteomics discloses petrosapongiolide M, an antiinflammatory marine sesterterpene, as a proteasome inhibitor.
Margarucci L; Monti MC; Tosco A; Riccio R; Casapullo A
Angew Chem Int Ed Engl; 2010 May; 49(23):3960-3. PubMed ID: 20376869
[No Abstract] [Full Text] [Related]
16. Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction.
van Dijk A; Krijnen PA; Vermond RA; Pronk A; Spreeuwenberg M; Visser FC; Berney R; Paulus WJ; Hack CE; van Milligen FJ; Niessen HW
Apoptosis; 2009 Jun; 14(6):753-63. PubMed ID: 19421861
[TBL] [Abstract][Full Text] [Related]
17. Binding to PLA2 may contribute to the anti-inflammatory activity of catechol.
Dileep KV; Tintu I; Mandal PK; Karthe P; Haridas M; Sadasivan C
Chem Biol Drug Des; 2012 Jan; 79(1):143-7. PubMed ID: 21995306
[TBL] [Abstract][Full Text] [Related]
18. Development of a second generation of inhibitors of microsomal prostaglandin E synthase 1 expression bearing the gamma-hydroxybutenolide scaffold.
Aquino M; Guerrero MD; Bruno I; Terencio MC; Paya M; Riccio R
Bioorg Med Chem; 2008 Oct; 16(19):9056-64. PubMed ID: 18790649
[TBL] [Abstract][Full Text] [Related]
19. Scalaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 Inactivation.
Monti MC; Casapullo A; Cavasotto CN; Napolitano A; Riccio R
Chembiochem; 2007 Sep; 8(13):1585-91. PubMed ID: 17691073
[TBL] [Abstract][Full Text] [Related]
20. Petrosaspongiolide M reduces morphine withdrawal in vitro.
Capasso A; Casapullo A; Randazzo A; Gomez-Paloma L
Life Sci; 2003 Jun; 73(5):611-6. PubMed ID: 12770615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
